Mode Evaluation in Sick Sinus Syndrome Trial (MODEST)

NCT00161551 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 402

Last updated 2011-08-02

No results posted yet for this study

Summary

The purpose of this study is to determine the incidence of atrial fibrillation and heart failure in patients with pacemaker therapy with different pacing modes (AAI, DDD, and a novel algorithm to minimize ventricular pacing).

Conditions

  • Sick Sinus Syndrome

Interventions

DEVICE

Vitatron T70 DR

Sponsors & Collaborators

  • Vitatron GmbH

    collaborator INDUSTRY
  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Volker Schibgilla, MD

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Completion
2010-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00161551 on ClinicalTrials.gov